MedPath

Allopurinol

ALLOPURINOL TABLETS USP

Approved
Approval ID

b2ab2389-ccaf-487b-9985-50e3539e7617

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 7, 2023

Manufacturers
FDA

PD-Rx Pharmaceuticals, Inc.

DUNS: 156893695

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Allopurinol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43063-975
Application NumberANDA071450
Product Classification
M
Marketing Category
C73584
G
Generic Name
Allopurinol
Product Specifications
Route of AdministrationORAL
Effective DateApril 7, 2023
FDA Product Classification

INGREDIENTS (1)

ALLOPURINOLActive
Quantity: 100 mg in 1 1
Code: 63CZ7GJN5I
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Allopurinol - FDA Drug Approval Details